10x Genomics, Inc. provided revenue guidance for the full year 2024. 10x Genomics expects full year 2024 revenue to be in the range of $670 million to $690 million, representing 8% to 12% growth over full year 2023 revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.25 USD | +2.69% | -7.41% | -63.81% |
Jun. 03 | Jefferies Initiates 10x Genomics at Hold Rating With $24 Price Target | MT |
May. 29 | 10x Genomics, Inc. Launches 5,000-Plex Gene Panel for Xenium | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.81% | 2.42B | |
-9.74% | 11.48B | |
-9.80% | 7.64B | |
+27.84% | 5.49B | |
-15.47% | 3.86B | |
+8.47% | 2.61B | |
-9.24% | 2.27B | |
+21.21% | 2.1B | |
-9.38% | 1.76B | |
-7.16% | 1.43B |
- Stock Market
- Equities
- TXG Stock
- News 10x Genomics, Inc.
- 10X Genomics, Inc. Provides Revenue Guidance for the Full Year 2024